Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M840Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M0.0EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)16.2Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %2.6PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M26,200,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CWI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
CWIKen Fisher 2015-03-31 Sold Out -0.003%$32.18 - $35.34
$ 32.06-6%Sold Out0
CWIKen Fisher 2014-12-31 Buy $32.85 - $35.5
$ 32.06-6%New holding43,919
CWIDodge & Cox 2012-03-31 Sold Out -0.0021%$25.22 - $28.4
$ 32.0617%Sold Out0
CWIDodge & Cox 2011-12-31 Buy $26.32 - $31.82
$ 32.0611%New holding51,300
CWIKen Fisher 2010-03-31 Sold Out $28.47 - $32.56
$ 32.064%Sold Out0
CWIKen Fisher 2009-12-31 Reduce$29.35 - $32.06
$ 32.063%Reduce -39.74%8,385
CWIKen Fisher 2009-09-30 Buy $24.2 - $30.96
$ 32.0614%New holding13,915
CWIKen Fisher 2009-06-30 Sold Out -0.02%$20.72 - $27.2585
$ 32.0632%Sold Out0
CWIThird Avenue Management 2009-03-31 Sold Out -0.14%$17.36 - $22.55
$ 32.0661%Sold Out0
CWIKen Fisher 2009-03-31 Reduce-0.02%$17.36 - $22.55
$ 32.0661%Reduce -86.98%166,015
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CWI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

CWI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BEST, SIMON GEOFFREYDirector 2016-10-07Buy2,750$2.93994.2view
Camilli, Kathleen MaryDirector 2016-10-07Buy5,000$4.99542.48view
Breault, Robert PaulDirector 2016-10-07Sell68,500$0.714415.49view
Meade, Harlan DonnleyDirector, Senior Officer 2016-10-07Buy3,000$0.1619937.5view
Lemasson, ClaudeDirector, Senior Officer 2016-10-07Buy100,000$0.83907.5view
ESTEPA, JORGEDirector or Senior Officer of 10% Security Holder, 2016-10-07Buy3,500$0.47915view
Griffiths, Richard Ian10% Security Holder 2016-10-07Buy89,500$07915view
Hinchcliffe, Robert10% Security Holder, Director, Senior Officer 2016-10-07Buy3,500$0.447186.36view
Reeson, DouglasDirector, Senior Officer 2016-10-07Buy15,000$0.0839975view
Anderson, Christopher RossDirector 2016-10-07Buy28,000$0.1422800view

Press Releases about CWI :

Quarterly/Annual Reports about CWI:

    News about CWI:

    Articles On GuruFocus.com
    Peter Lynch LUVs Southwest Airlines Oct 26 2016 
    FireEye Is a Toxic Stock Oct 26 2016 
    The Dangers of Dividend Obsession Oct 26 2016 
    Eldorado Gold Will Release 3rd Quarter Results Tomorrow Oct 26 2016 
    Eaton Vance Worldwide Health Sciences Fund 3rd Quarter Commentary Oct 26 2016 
    Dividend Aristocrats in Focus Part 17: V.F. Corp. Oct 26 2016 
    Dividend Aristocrats in Focus Part 16: S&P Global Oct 26 2016 
    Hell or High Water Oct 26 2016 
    Bill Miller: Valeant Can Double in 3 Years Oct 26 2016 
    Newmont's 3rd Quarter Estimates Oct 26 2016 

    More From Other Websites
    Allergan Generics Has Strengthened Teva’s Research Pipeline Sep 30 2016
    Teva Is Well Placed to Dominate the European Generics Market Sep 28 2016
    Teva’s Generic Value Chain Differentiates It from Its Peers Sep 27 2016
    Teva Pharmaceutical Expected to See Strong Revenue Growth in 2016 Aug 23 2016
    7 ETFs for a Lower Return Outlook Jul 26 2016
    Quality Works For This Emerging Markets ETF May 09 2016
    Teva: Developments in the Migraine Prevention Segment Apr 06 2016
    Bendeka: How Teva Plans to Safeguard Oncology Revenues Apr 01 2016
    The Zacks Analyst Blog Highlights: Vanguard Total World Stock ETF, iShares MSCI ACWI ETF, SPDR MSCI... Mar 03 2016
    Build a Global Diversified Portfolio with These ETFs Mar 02 2016
    Is it time for U.S. investors to look abroad? Feb 23 2016
    4 Global ETFs to Outperform in Q1 Feb 05 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)